What is the price target for ABLD stock?
7 analysts have analysed ABLD.PA and the average price target is 8.54 EUR. This implies a price increase of 200.61% is expected in the next year compared to the current price of 2.84.
ABL DIAGNOSTICS (ABLD.PA) Forecast, Price Target & Analyst Ratings
EPA:ABLD • FR001400AHX6
Current stock price
2.84 EUR
+0.04 (+1.43%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ABL DIAGNOSTICS (ABLD.PA).
Forecast Snapshot
Price Target Details & History
Consensus Price Target and Range
Mean target
€8.54
Upside
+ 200.61%
From current price of €2.84 to mean target of €8.54, Based on 7 analyst forecasts
Low
€8.45
Median
€8.54
High
€8.79
Price Target Revisions
1 Month
0.00%
3 Months
35.88%
Price Target Summary
7 Wall Street analysts provided a forecast for the next 12 months for ABLD.PA. The average price target is 8.54 EUR. This implies a price increase of 200.61% is expected in the next year compared to the current price of 2.84.
The average price target has been revised upward by 35.88% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
82.86%
ABLD.PA was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about ABLD.PA.
In the previous month the buy percentage consensus was at a similar level.
ABLD.PA was analyzed by 7 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- N/A
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates 2025 - 2027
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 8.749M | 5.613M -35.84% | 5.33M -5.03% | 7.579M 42.18% | 10.853M 43.20% | 15.259M 40.60% | |
| EBITDA YoY % growth | N/A | N/A | N/A | 1.081M -32.94% | 2.234M 106.66% | 3.641M 62.98% | |
| EBIT YoY % growth | 59.3K 157.80% | -657.1K -1,208.09% | -490.4K 25.37% | 51K 110.40% | 1.234M 2,319.61% | 2.54M 105.83% | |
| Operating Margin | 0.68% | -11.71% | -9.20% | 0.67% | 11.37% | 16.65% | |
| EPS YoY % growth | N/A | N/A | N/A | 0.05 66.67% | 0.06 20.00% | 0.12 100.00% |
All data in EUR
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in EUR
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
58.74%
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
33.13%
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
133.61%
EBIT Next 5 Year
N/A
ABL DIAGNOSTICS / ABLD.PA Forecast FAQ
What is the number of analysts for ABLD stock?
The number of analysts covering ABL DIAGNOSTICS (ABLD.PA) is 7.